U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07294794) titled 'Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension' on Dec. 08.
Brief Summary: High blood pressure (hypertension) affects 1 in 3 adults and can lead to serious health issues like strokes and heart attacks. Medication can lower blood pressure (BP) and reduce complications. Choosing the right medication can be challenging, potentially leading to side effects or poor control.
HYPERMARKER is testing whether providing doctors with additional information when they make a blood pressure prescription choice can improve a patient's overall blood pressure management. This includes relevant clinical ...